Lee Jae-Hwan, Pidaparti Ramana M, Atkinson Gary M, Moorthy Ramana S
Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA 23284, USA.
J Drug Deliv. 2012;2012:527516. doi: 10.1155/2012/527516. Epub 2012 Jul 18.
Ocular diseases, such as, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and retinitis pigmentosa require drug management in order to prevent blindness and affecting million of adults in USA and worldwide. There is an increasing need to develop devices for drug delivery to address ocular diseases. This study focuses on the design, simulation, and development of an implantable ocular drug delivery device consisting of micro-/nanochannels embedded between top and bottom covers with a drug reservoir made from polydimethylsiloxane (PDMS) which is silicon-based organic and biodegradable polymer. Several simulations were carried out with six different micro-channel configurations in order to see the feasibility for ocular drug delivery applications. Based on the results obtained, channel design of osmotic I and osmotic II satisfied the diffusion rates required for ocular drug delivery. Finally, a prototype illustrating the three components of the drug delivery design is presented. In the future, the device will be tested for its functionality and diffusion characteristics.
眼部疾病,如青光眼、年龄相关性黄斑变性(AMD)、糖尿病视网膜病变和色素性视网膜炎,需要药物治疗以预防失明,这些疾病影响着美国及全球数百万成年人。开发用于眼部给药的装置的需求日益增加。本研究聚焦于一种可植入眼部给药装置的设计、模拟和开发,该装置由嵌入上下盖之间的微/纳米通道组成,带有一个由聚二甲基硅氧烷(PDMS)制成的药物储存器,PDMS是一种基于硅的有机可生物降解聚合物。为了考察其在眼部给药应用中的可行性,对六种不同的微通道配置进行了多次模拟。根据所得结果,渗透I和渗透II的通道设计满足了眼部给药所需的扩散速率。最后,展示了一个说明给药设计三个组成部分的原型。未来,将对该装置的功能和扩散特性进行测试。